Apex Scientific

21+ access.
Research use only.

Before entering, confirm that you meet the age requirement and understand the research-use limitations that apply to every Apex product.

Your email is used for site access, checkout, account, and order communications. This step does not subscribe you to marketing. Read the Privacy Notice, Research Use Policy, and Terms.

Leave site

Your acknowledgement is remembered on this device for 30 days.

Research use only Clear product information Free shipping on orders over $200 20% launch offer · Use code APEX101
Apex Scientific
Bag 0

Compound guide

CJC-1295 / IPAMORELIN

From cellular signaling to what those pathways mean in everyday language.

Overview

A Summary:CJC-1295 / IPAMORELIN

This blend combines CJC-1295, a long-acting GHRH analogue, with ipamorelin, a growth-hormone secretagogue that acts through the ghrelin receptor pathway.

This blend combines two signals that approach the same pituitary output from different receptors. CJC-1295 imitates growth hormone-releasing hormone, while ipamorelin activates the ghrelin receptor pathway.

Inside the body

Cellular & MolecularHow CJC-1295 / IPAMORELIN Functions

These receptors, enzymes, and signaling networks form the primary steps connecting this compound with changes inside cells and tissues.

01CJC-1295 input

GHRH receptor

At the cellular or molecular level

CJC-1295 is a GHRH analogue. Binding to the Gs-coupled GHRH receptor raises cyclic AMP and protein kinase A activity in pituitary somatotroph cells, supporting growth-hormone synthesis and release.

02Ipamorelin input

Ghrelin receptor / GHSR1a

At the cellular or molecular level

Ipamorelin activates the growth-hormone secretagogue receptor. This receptor mainly signals through Gq proteins, phospholipase C, intracellular calcium, and related pathways that trigger hormone release.

03Shared downstream effect

GH / IGF-1 axis

At the cellular or molecular level

Growth hormone released from the pituitary acts on liver and peripheral tissues through JAK2 and STAT signaling. Liver production of IGF-1 is one measurable downstream response.

In plain English

What those pathways mean.

01

CJC-1295 input

Small studies reported longer-lasting increases in growth hormone and IGF-1.

02

Ipamorelin input

The pathway can create a growth-hormone pulse, but human outcome evidence for ipamorelin is sparse.

03

Shared downstream effect

This axis affects metabolism, tissue growth, and glucose handling throughout the body.

How the signals work together

CJC-1295 raises cyclic-AMP signaling and ipamorelin raises calcium-linked signaling inside pituitary cells. Both routes can converge on growth-hormone release, which then activates the liver and tissue GH–IGF-1 axis.

Read the evidence

Sources BehindThis Guide

CJC-1295 pharmacology studyIpamorelin receptor researchCJC-1295 identity recordIpamorelin identity record

One important note

Educational Notice

Small human studies measured hormone changes from CJC-1295, while ipamorelin evidence is primarily receptor and pharmacology research. The fixed blend has not been evaluated in controlled human outcome trials.

This guide explains cellular mechanisms and published outcomes in everyday language. It is educational information, not medical advice or instructions for personal use. Products offered on this site are intended exclusively for laboratory research and are not for human or veterinary use.